Close Asset Management’s Moderna MRNA Stock Holding History

Close Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-75	Closed	-$2K	–	283
2025 Q4	$2K	Hold	75	–	–	﹤0.01%	260
2025 Q3	$2K	Sell	75 -100	-57%	-$2.79K	﹤0.01%	254
2025 Q2	$5K	Sell	175 -500	-74%	-$13.2K	﹤0.01%	230
2025 Q1	$19K	Hold	675	–	–	﹤0.01%	192
2024 Q4	$28K	Hold	675	–	–	﹤0.01%	176
2024 Q3	$45K	Hold	675	–	–	﹤0.01%	166
2024 Q2	$80K	Buy	675 +75	+13%	+$9.49K	﹤0.01%	146
2024 Q1	$64K	Buy	600 +250	+71%	+$25.2K	﹤0.01%	151
2023 Q4	$35K	Hold	350	–	–	﹤0.01%	162
2023 Q3	$36K	Buy	350 +80	+30%	+$8.92K	﹤0.01%	153
2023 Q2	$33K	Buy	270 +250	+1,250%	+$33.4K	﹤0.01%	173
2023 Q1	$3K	Buy	+20	New	+$3.3K	﹤0.01%	220
2021 Q4	–	Sell	-36	Closed	-$14K	–	211
2021 Q3	$14K	Buy	+36	New	+$13.3K	﹤0.01%	178

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return